Humacyte (HUMA) Current Leases (2020 - 2026)

Humacyte (HUMA) has 7 years of Current Leases data on file, last reported at $2.4 million in Q1 2026.

• Current Leases for Q1 2026 came in at $2.4 million, down 19.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (down 19.23% YoY), and the FY2025 annual result was $2.4 million, down 16.76% from the prior year.
• Current Leases held at $2.4 million in Q1 2026 per HUMA's latest filing, from $2.4 million in the prior quarter.
• Over five years, Current Leases peaked at $3.1 million in Q2 2025 and troughed at $46000.0 in Q1 2022.
• A 5-year average of $2.3 million and a median of $2.5 million in 2023 frame the typical range for Current Leases.
• The sharpest annual moves came in 2023 and 2024: Current Leases slumped 97.59% in 2023, then jumped 5284.31% in 2024.
• A 5-year view of Current Leases shows it stood at $2.3 million in 2022, then increased by 13.48% to $2.6 million in 2023, then climbed by 13.95% to $2.9 million in 2024, then dropped by 16.76% to $2.4 million in 2025, then changed by 0.0% to $2.4 million in 2026.
• Business Quant data shows HUMA's Current Leases at $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $2.7 million in Q3 2025.